# PubMed record PMID 30764032

> PeptideScanner retained PubMed bibliographic metadata for PMID 30764032 at 2026-07-30T20:44:20.588Z. PubMed recorded a metadata revision date of 2019-11-20 and an Entrez history date of 2019-02-16. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-30764032-tesamorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-11-20
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-30764032-tesamorelin/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-30764032-tesamorelin-v1.json
- Content SHA-256: `4d0b80bffb58963dd6a308e2a0597627ed01988920534373b9f8eeada59bb499`

## Claims and source pins

### Headline

PubMed record PMID 30764032 ([`pubmed-observation-pmid-30764032-2019-11-20-257b389361f9`](#source-pubmed-observation-pmid-30764032-2019-11-20-257b389361f9))

### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 30764032 at 2026-07-30T20:44:20.588Z. PubMed recorded a metadata revision date of 2019-11-20 and an Entrez history date of 2019-02-16. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-30764032-2019-11-20-257b389361f9`](#source-pubmed-observation-pmid-30764032-2019-11-20-257b389361f9))

### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 30764032 at 2026-07-30T20:44:20.588Z. PubMed recorded a metadata revision date of 2019-11-20 and an Entrez history date of 2019-02-16. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-30764032-2019-11-20-257b389361f9`](#source-pubmed-observation-pmid-30764032-2019-11-20-257b389361f9))

### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-30764032-2019-11-20-257b389361f9`](#source-pubmed-observation-pmid-30764032-2019-11-20-257b389361f9))

## Sources

<a id="source-pubmed-observation-pmid-30764032-2019-11-20-257b389361f9"></a>
- **PubMed record PMID 30764032 · retained source version 1:2019-11-20:current:257b389361f90d7a3a96101b8596dbeb1ac99ae3bbbca0a9133b99365ece38ef** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/30764032/) (`pubmed-observation-pmid-30764032-2019-11-20-257b389361f9`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "PubMed record PMID 30764032." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-30764032-tesamorelin-v1.json SHA-256: 4d0b80bffb58963dd6a308e2a0597627ed01988920534373b9f8eeada59bb499.

